Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The objective of this study is to confirm the clinical safety and efficacy of Viscontour® Serum Med in the hydration of facial tissue.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Viscontour® Serum Med | Device | Viscontour® Serum Med is a CE-certified preservative-free isotonic solution containing 5.0 mg sodium hyaluronate. |
| Measure | Description | Time Frame |
|---|---|---|
| Change of Skin Parameters compared to Baseline | Routine Evaluation of the Overall Skin Condition | 20 Minutes, Day 7 and Day 28 |
| Change of Subjective Therapy Evaluation (Questionnaire) compared to Baseline | 20 Minutes, Day 7 and Day 28 | |
| Incidence of Treatment-Emergent Adverse Events | Up to Day 28 |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Patients with a Viscontour® Serum Med therapy recommendation (i.a. for hydration, soothing, nourishing and refreshing the complexion and for use in combination with a day cream)
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Praxis Dr. Dirk Gröne | Berlin | 14052 | Germany |
Not provided
Not provided
Not provided
Not provided